| ²é¿´: 274 | »Ø¸´: 1 | |||
ľ¶¹Ò¶Òø³æ (СÓÐÃûÆø)
|
[ÇóÖú]
̼Æ×ÇóÖú28-1 ÒÑÓÐ1È˲ÎÓë
|
| ÈܼÁMeOD£º14.40,20.88,23.57,30.30,32.49,33.57,35.10,42.81,65.11,72.54,75.61,81.64,81.79,113.05,130.93,135.23,140.51,153.37,165.54,174.06 |
» ²ÂÄãϲ»¶
±¾9Ò»Ö¾Ô¸2 0854µÍ·Öר˶286Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
070300»¯Ñ§Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
329Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
085701Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
26¿¼Ñе÷¼Á0710 0860
ÒѾÓÐ7È˻ظ´
²ÄÁÏרҵ383Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
Ò»Ö¾Ô¸±±¾©¿Æ¼¼´óѧ²ÄÁϹ¤³Ì085601£¬Çóµ÷¼Á
ÒѾÓÐ17È˻ظ´
Ò»Ö¾Ô¸Ö£ÖÝ´óѧ²ÄÁÏÓ뻯¹¤085600£¬Çóµ÷¼Á
ÒѾÓÐ19È˻ظ´
085600£¬×¨Òµ¿Î»¯¹¤ÔÀí£¬321·ÖÇóµ÷¼Á
ÒѾÓÐ8È˻ظ´
ÇóÉúÎïѧµ÷¼Á
ÒѾÓÐ11È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
½âÆ×ÇóÖú£¨Ö»ÓÐ̼Æ×£©£¬Ð»Ð»ÁË¡£
ÒѾÓÐ3È˻ظ´
̼Æ×ÇóÖú£¡Ð»Ð»£¡
ÒѾÓÐ3È˻ظ´
΢Æ×ÇóÖú£¬Ð»Ð» £¨TE1-1£©
ÒѾÓÐ3È˻ظ´
ÇóÖú΢Æ×Êý¾Ý1¸ö
ÒѾÓÐ3È˻ظ´
̼Æ×Ϊʲô»ý·Ö³öÏÖ¸ºÖµ°¡£¡
ÒѾÓÐ13È˻ظ´
΢Æ×ÇóÖú£¡¼±¼±¼±£¬Ð»Ð»£¡
ÒѾÓÐ3È˻ظ´
ÇóÖúDDHQ̼Æ×½âÎö
ÒѾÓÐ4È˻ظ´
ÇóÖú΢Æ×Êý¾Ý£¬Ð»Ð»
ÒѾÓÐ7È˻ظ´
ÇóÖú΢Æ×Êý¾Ý£¬Ð»Ð»
ÒѾÓÐ3È˻ظ´
ÇóÖúÇâÆ×̼Æ× ·ÖÎö~~~
ÒѾÓÐ4È˻ظ´
¡¾ÇóÖú¡¿·ÖÀëÌá´¿µÃµ½µÄ»¯ºÏÎï¼òµ¥ÇâÆ×ºÍ̼Æ×½âÎö
ÒѾÓÐ10È˻ظ´
[ÇóÖú]ÑùƷ̼Æ×Ò»¸öÎÊÌâ
ÒѾÓÐ7È˻ظ´
¡¾ÇóÖú¡¿¹ØÓÚ̼Æ×Öп¨±ö̼µÄλÖÃ
ÒѾÓÐ4È˻ظ´
¡¾ÇóÖú¡¿¼±£¡£¡£¡¼±£¡£¡ÇóÖúºË´Å¹²ÕñµÄ̼Æ×ÇâÆ×½âÎö
ÒѾÓÐ15È˻ظ´
¡¾ÇóÖú¡¿ÓйØÌ¼Æ×ÔÓ·åµÄÎÊÌ⣡
ÒѾÓÐ12È˻ظ´
¡¾ÇóÖú¡¿ë®´ø»¯ºÏÎï̼Æ× Çó½âÊÍ
ÒѾÓÐ10È˻ظ´
¡¾ÇóÖú¡¿´ó¼Ò¿´¿´Õâ¸öÕâ¸ö̼Æ×ÊÇ·ñ¶ÔÓ¦Õâ¸ö½á¹¹£¿
ÒѾÓÐ12È˻ظ´
¡¾ÇóÖú¡¿ËÖªµÀÄÄÀï¿ÉÒԲ黯ºÏÎïµÄ̼Æ×°¡£¿
ÒѾÓÐ10È˻ظ´
¡¾ÇóÖú¡¿Çë½ÌÓÃʲôÈí¼þ¿ÉÒÔÐÞ¸ÄÇâÆ×ºÍ̼Æ×µÄÆ×ͼ£¿
ÒѾÓÐ15È˻ظ´
¡¾ÇóÖú¡¿Ì¼Æ×ºË´Å
ÒѾÓÐ7È˻ظ´
¡¾ÇóÖú¡¿Ì¼Æ×È¥ñîÎÊÌâ
ÒѾÓÐ10È˻ظ´
¡¾ÇóÖú¡¿²úÆ·ºË´ÅÇâÆ×̼Æ×´ò³öÀ´¶¼¶Ô£¬µ«ÊÇÒºÏà´ò³öÀ´ÂÒÆß°ËÔã
ÒѾÓÐ21È˻ظ´
¡¾ÇóÖú¡¿´ò̼Æ×ºÍÇâÆ×£¬ÎÒµÄÑùÆ·¹»²»¹»°¡
ÒѾÓÐ10È˻ظ´
seuseasoar
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 2238 (½²Ê¦)
- ½ð±Ò: 48394.9
- ºì»¨: 52
- Ìû×Ó: 6742
- ÔÚÏß: 546.4Сʱ
- ³æºÅ: 2400995
- ×¢²á: 2013-04-01
- ÐÔ±ð: MM
- רҵ: ʳƷ¿ÆÑ§»ù´¡
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ľ¶¹Ò¶: ½ð±Ò+10, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2015-03-24 15:47:36
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ľ¶¹Ò¶: ½ð±Ò+10, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2015-03-24 15:47:36
|
. Compound 17 ÏàËÆ¶È:57.1% Bioorganic & Medicinal Chemistry Letters 2007 17 2634-2638 Epoxygenase eicosanoids: Synthesis of tetrahydrofuran-diol metabolites and their vasoactivity J.R. Falck, L. Manmohan Reddy, Kihwan Byun, William B. Campbell, Xiu-Yu Yi Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 2 . sphingofungin E C21H39NO7 ÏàËÆ¶È:57.1% The Journal of Antibiotics 1992 45 1692-1696 SPHINGOFUNGINS E AND F: NOVEL SERINEPALMITOYL TRANS-FERASE INHIBITORS FROM Paecilomyces variotii WENDY S. HORN, JACK L. SMITH, GERALD F. BILLS, SUSAN L. RAGHOOBAR, GREGORY L. HELMS, MYRA B. KURTZ, JEAN A. MARRINAN, BETH R. FROMMER, ROSEMARY A. THORNTON, SUZANNE M. MANDALA Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 3 . compound 27c C21H34ON2S ÏàËÆ¶È:55% Canadian Journal of Chemistry 2007 85 603-618 Efficient preparation of chiral non-racemic sulfur compounds Joannie Minville, M¨¦lina Girardin, and Claude Spino Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 4 . compound 28c C21H34ON2S ÏàËÆ¶È:55% Canadian Journal of Chemistry 2007 85 603-618 Efficient preparation of chiral non-racemic sulfur compounds Joannie Minville, M¨¦lina Girardin, and Claude Spino Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 5 . sphingofungin E C21H39NO7 ÏàËÆ¶È:55% Organic letters 2002 4 151-154 Total Synthesis of Sphingofungin E from d-Glucose Takeshi Oishi, Koji Ando, Kenjin Inomiya, Hideyuki Sato, Masatoshi Iida, and Noritaka Chida Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 6 . compound 2 ÏàËÆ¶È:55% Phytochemistry 1977 16 1841 The use of 13C-NMR in the determination of structures: A correction of the structure of borjatriol Seraf¨ªn Valverde, Benjam¨ªn Rodr¨ªguez Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 7 . 15-epi-lipoxin A4 ÏàËÆ¶È:55% Tetrahedron Letters 2001 42 6057-6060 Total synthesis of aspirin-triggered 15-epi-lipoxin A4 Ana R Rodrı́guez, Bernd W Spur Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 8 . (1S,2E,4S,6E,8R,11S,12E)-8,11-epoxy-2,6,12-cembratrien-4-ol C20H32O2 ÏàËÆ¶È:55% Acta Chemica Scandinavica 1980 34B 195-202 Tobacco Chemistry. 51. New Cembranic Diterpenoids from Greek Tobacco. Behr, Dan; Wahlberg, Inger; Nishida, Toshiaki; Enzell, Curt R.; Berg, Jan-Erik; Pilotti, Anne-Marie Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 9 . Biverlactone B C19H30O5 ÏàËÆ¶È:55% Tetrahedron 2011 67 6644-6648 Biverlactones A¨CD, new circumventors of arbekacin resistance in MRSA, produced by Penicillium sp. FKI-4429 Masato Iwatsuki, Toshiya Ishimori, Tsuyoshi Yamamoto, Keiko Takata, Mihoko Mori, Kenichi Nonaka, Rokuro Masuma, Yoichi Hayakawa, Hideaki Hanaki, Kazuro Shiomi, Satoshi ¨mura Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 10 . ethyl 3-O-benzoyl-5,6,7,8,9-pentadeoxy-1,2-O-isopropylidene-¦Á-D-xylo-dec-5(E)-enofuranuronate ÏàËÆ¶È:55% Bioorganic & Medicinal Chemistry 2008 16 5090-5102 S-Ribosylhomocysteine analogues with the carbon-5 and sulfur atoms replaced by a vinyl or (fluoro)vinyl unit Stanislaw F. Wnuk, Jennifer Lalama, Craig A. Garmendia, Jenay Robert, Jinge Zhu, Dehua Pei Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 11 . (Z)-{1-(hydroxymethyl)-4-[4-methyl-3-(methylethyl)-pent-2-enylidene]-3-oxo-2-oxolanyl}methyl butanoate C19H30O5 ÏàËÆ¶È:55% Journal of Medicinal Chemistry 2000 43 921-944 Conformationally Constrained Analogues of Diacylglycerol (DAG). 16.1 How Much Structural Complexity Is Necessary for Recognition and High Binding Affinity to Protein Kinase C? Kassoum Nacro, Bruno Bienfait, Jeewoo Lee, Kee-Chung Han, Ji-Hye Kang, Samira Benzaria, Nancy E. Lewin, Dipak K. Bhattacharyya, Peter M. Blumberg, and Victor E. Marquez Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 12 . compound 20 C21H32O4 ÏàËÆ¶È:55% Heterocycles 2015 90 579−599 Studies toward the Total Synthesis of Amphidinolide N: Stereocontrolled Synthesis of the C13¨CC29 Segment Makoto Sasaki, * Yuki Kawashima, and Haruhiko Fuwa Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ |

2Â¥2015-03-24 12:15:44














»Ø¸´´ËÂ¥